Tab Article
Key Features
- This comprehensive book on Cardio-Kidney Metabolic Medicine underscores the global necessity for integrated care models to combat interconnected threats like obesity—a looming cardiometabolic crisis extending from childhood phenotypes to overlooked sarcopenic obesity and epicardial fat as key biomarkers.
- It explores antiobesity medications' evolution, bariatric surgery advances, and the reality of diabetes remission, bolstered by CGM breakthroughs in glycemic control.
- Innovations in hypertension management, MASLD's link to ASCVD, and strategies against HF in diabetes—from HFpEF perspectives to hyperkalemia roadblocks—are demystified alongside SGLT2 inhibitors' blockbuster impact and 2025 hypertension drugs.
- Cutting-edge chapters on digital twins, AI in clinics, and 2026 digital diabetes care herald personalized, tech-driven futures.













Guest
Verified PurchaseNice